Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy

Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting while minimizing collateral systemic side effe...

Full description

Bibliographic Details

Published in:	CNS Oncology
Main Authors:	Joshua Loya, Charlie Zhang, Emily Cox, Achal S Achrol, Santosh Kesari
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-11-01
Subjects:	cell therapy enzyme/prodrug therapy high-grade glioma intratumoral delivery oncolytic virus radioimmunotherapy
Online Access:	https://www.futuremedicine.com/doi/10.2217/cns-2019-0002